KO vs MBRX · P/E 25, rev $47.94B vs $8.2M cap
The Coca-Cola Company (KO) versus Moleculin Biotech Inc (MBRX) — a side-by-side from cached financials, not a winner call.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
KO currently screens at market cap $343.90B and trailing P/E 25.1. MBRX currently screens at market cap $8.2M.
Not investment advice. Open the KO and MBRX stock pages for the full models.
Not investment advice.